腹主动脉瘤修复术后高血糖相关结局
基于Cerner Health Facts数据库2008年9月至2014年3月非破裂腹主动脉瘤开放或腔内修复患者,术后高血糖(血糖>180 mg/dL)与感染、住院死亡、再入院、住院时间及用药相关;多变量模型显示高血糖与感染和住院死亡风险升高相关,但回顾性设计不能推断因果关系,需前瞻性研究。
要点
- 2478例中407例(16.5%)术后高血糖,其住院时间9.5天 vs 4.7天(P<.0001)、感染率18% vs 8%(P<.0001)、住院死亡率8.4% vs 1.2%(P<.0001)。
- 术后使用胰岛素者感染并发症的OR为1.6(95%CI 1.12-2.2;P=.007)。
- 高血糖患者住院死亡的OR为3.48(95%CI 1.78-6.80;P=.0003)。
核心结论
- 择期腹主动脉瘤修复患者中约六分之一出现术后高血糖,高血糖与住院死亡和感染等不良事件相关。
- 与开放手术相比,术后高血糖的腔内修复患者感染和死亡风险更高。
- 控制胰岛素使用和术后高血糖后,糖尿病诊断与感染和住院死亡风险降低相关。
- 作者认为高血糖可作为临床标志物,但回顾性研究不能推断因果关系,需前瞻性研究阐明术后高血糖与患者结局的关系。
研究设计与样本
- 使用Cerner Health Facts数据库,通过ICD-9-CM诊断和操作代码识别2008年9月至2014年3月接受非破裂腹主动脉瘤开放或腔内修复的患者。
- 评估术后高血糖(血糖浓度>180 mg/dL)与感染、住院死亡、再入院、患者特征、住院时间和药物的关联。
- 采用多变量logistic模型分析术后高血糖与住院感染和死亡的关系。
主要发现
- 2478例患者中2071例(83.5%)术后血糖控制良好(80-180 mg/dL),407例(16.5%)血糖控制欠佳(高血糖)。
- 术后高血糖患者住院时间9.5天 vs 4.7天(P<.0001)、感染率18% vs 8%(P<.0001)、住院死亡率8.4% vs 1.2%(P<.0001),且急性并发症更多(即急性肾衰竭、液体和电解质紊乱、呼吸系统并发症)。
- 调整患者特征和药物后,术后使用胰岛素者发生感染并发症的OR为1.6(95%CI 1.12-2.2;P=.007)。
- 高血糖患者住院死亡的OR为3.48(95%CI 1.78-6.80;P=.0003),高血糖患者死亡率2.3% vs 1.2%(P<.001)。
- 按手术类型分层,腔内修复的高血糖患者感染并发症OR为1.85(95%CI 0.98-3.51;P=.05),住院死亡OR为7.54(95%CI 1.95-29.1;P=.003)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 本研究为回顾性研究,不能推断因果关系。
- 需要采用前瞻性方法进一步研究,以阐明术后高血糖与患者结局之间的关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We evaluated the association between postoperative hyperglycemia and outcomes after abdominal aortic aneurysm (AAA) repair. METHODS: We used diagnosis and procedure codes (International Classification of Diseases, Ninth Revision, Clinical Modification) to identify patients who underwent open or endovascular repair of a nonruptured AAA from September 2008 to March 2014 from the Cerner Health Facts database (Cerner Corporation, North Kansas City, Mo). We evaluated the association between postoperative hyperglycemia (glucose concentration >180 mg/dL) and infections, in-hospital mortality, readmission, patients' characteristics, length of hospital stay, and medications. Multivariable logistic models examined the association of postoperative hyperglycemia with in-hospital infection and mortality. RESULTS: Of 2478 patients, 2071 (83.5%) had good postoperative glucose control (80-180 mg/dL), and 407 (16.5%) had suboptimal control (hyperglycemia). Patients who had postoperative hyperglycemia experienced longer hospital stays (9.5 vs 4.7 days; P < .0001), higher infection rates (18% vs 8%; P < .0001), higher in-hospital mortality (8.4 vs 1.2%; P <.0001), and more acute complications (ie, acute renal failure, fluid and electrolyte disorders, respiratory complications). After adjusting for patients' characteristics and medications, multivariable logistic regression models demonstrated that patients receiving postoperative insulin had nearly 1.6 times the odds of having an infectious complication (odds ratio [OR], 1.6; 95% confidence interval [CI], 1.12-2.2; P = .007) than those who did not. Hyperglycemic patients had 3.5 times the odds of in-hospital mortality (OR, 3.48; 95% CI, 1.78-6.80 [P = .0003]; 2.3% vs 1.2%; P < .001). When stratified by procedure type, patients with hyperglycemia who underwent endovascular repair had nearly 2 times the odds of an infectious complication (OR, 1.85; 95% CI, 0.98-3.51; P = .05) and 7.5 times the odds of in-hospital mortality (OR, 7.54; 95% CI, 1.95-29.1; P = .003). Patients who underwent an open AAA repair and who had hyperglycemia had three times the odds of dying in the hospital (OR, 3.05; 95% CI, 1.29-7.21; P = .01). CONCLUSIONS: Among patients undergoing elective AAA repair, approximately one in six had postoperative hyperglycemia. After AAA repair in patients with and without diabetes, postoperative hyperglycemia was associated with adverse events, including in-hospital mortality and infections. Compared with those who had open surgery, patients undergoing endovascular repair who had postoperative hyperglycemia had greater risk of infection and death. After controlling for insulin administration and postoperative hyperglycemia, a diabetes diagnosis was associated with lower odds of both infection and in-hospital mortality. Our study suggests that hyperglycemia may be used as a clinical marker as it was found to be significantly associated with inferior outcomes after elective AAA repair. This retrospective study, however, cannot imply causation; further study using prospective methods is needed to elucidate the relationship between postoperative hyperglycemia and patient outcomes.
引用
- Tarbunou YA, Smith JB, Kruse RL, et al. Outcomes associated with hyperglycemia after abdominal aortic aneurysm repair. J Vasc Surg. 2018. PMID: 30154015. doi:10.1016/j.jvs.2018.05.240
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。